The Ohio Attorney General's Office will announce Tuesday the expansion of an agreement with a Naloxone manufacturer regarding rebates for public entities that purchase the drug.
Last year Mike DeWine announced that manufacturer Amphastar had agreed to provide a $6 rebate for each Amphastar naloxone syringe purchased by non-federal public entities in Ohio.
That agreement has been extended for another year, the attorney general's office told newsnet5.com.
Naloxone is a medication that blocks the effects of opiates, like heroin, during an overdose.
The company agreed to provide the rebate after DeWine wrote a letter in response to its price increase for the life-saving drug.
According to the attorney general's office, during the first year of the agreement, agencies have applied for more than $151,000 in rebates.
